UCB, a global biopharmaceutical company, today announced positive data from studies involving its investigational pyrimidine nucleoside therapy, doxecitine (dC) and doxribtimine (dT), in people living ...

UCB, a global biopharmaceutical company, today announced positive data from studies involving its investigational pyrimidine nucleoside therapy, doxecitine (dC) and doxribtimine (dT), in people living ...

Satellos Bioscience Inc. (TSX: MSCL, OTCQB: MSCLF) ("Satellos" or the "Company"), a biotech company developing new small molecule therapeutic approaches to improve the treatment of muscle diseases and ...

New Evrysdi five-year data from the SUNFISH study showed continued stabilisation of motor function in a broad population of ind ...

Roche to present latest scientific advancements from its neuromuscular portfolio at Muscular Dystrophy Association 2025 conference: Basel Tuesday, March 18, 2025, 11:00 Hrs [IST] ...

Having the money talk with your aging parents doesn’t have to feel like an ambush. With the right approach, you can turn it into a productive conversation that brings you closer together. Learn top ...

Sarepta Therapeutics has followed through on its promise to file for accelerated approval of its gene therapy SRP-9001 for Duchenne muscular dystrophy ... measures of physical ability, although ...

Ivy Rehab ("Ivy" or the "Company"), a provider of outpatient adult and pediatric physical, occupational and speech therapy, as well as ABA services, announced today that Michael Rucker, its Chief ...

CNW/ - Eight finalists have been announced by the Canadian Journalism Forum on Violence and Trauma for the 2024 Mindset ...

By Pooja Mamnoor Click here for updates on this story 3/17/25 (LAPost.com) — Jennifer Kucera, a 55-year-old Ohio resident with muscular dystrophy, relies on daily caregivers to help her get out of bed ...